Global Human Hepatitis B Immunoglobulin (IM) Market Research Report 2020

Global Human Hepatitis B Immunoglobulin (IM) Market Research Report 2020

Table of Contents
1 Human Hepatitis B Immunoglobulin (IM) Market Overview
1.1 Product Overview and Scope of Human Hepatitis B Immunoglobulin (IM)
1.2 Human Hepatitis B Immunoglobulin (IM) Segment by Type
1.2.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin (IM)
1.3 Human Hepatitis B Immunoglobulin (IM) Segment by Application
1.3.1 Human Hepatitis B Immunoglobulin (IM) Sales Comparison by Application: 2020 VS 2026
1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
1.3.3 Unexpected Crowd of Hepatitis B Infection
1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.4 Global Human Hepatitis B Immunoglobulin (IM) Market Size Estimates and Forecasts
1.4.1 Global Human Hepatitis B Immunoglobulin (IM) Revenue 2015-2026
1.4.2 Global Human Hepatitis B Immunoglobulin (IM) Sales 2015-2026
1.4.3 Human Hepatitis B Immunoglobulin (IM) Market Size by Region: 2020 Versus 2026
2 Global Human Hepatitis B Immunoglobulin (IM) Market Competition by Manufacturers
2.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers (2015-2020)
2.3 Global Human Hepatitis B Immunoglobulin (IM) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Hepatitis B Immunoglobulin (IM) Manufacturing Sites, Area Served, Product Type
2.5 Human Hepatitis B Immunoglobulin (IM) Market Competitive Situation and Trends
2.5.1 Human Hepatitis B Immunoglobulin (IM) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Human Hepatitis B Immunoglobulin (IM) Players (Opinion Leaders)
3 Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario by Region
3.1 Global Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Human Hepatitis B Immunoglobulin (IM) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Country
3.3.1 North America Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.3.2 North America Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Country
3.4.1 Europe Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.4.2 Europe Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Region
3.5.1 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Region
3.5.2 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Country
3.6.1 Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.6.2 Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.7.2 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Hepatitis B Immunoglobulin (IM) Historic Market Analysis by Type
4.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type (2015-2020)
4.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Type (2015-2020)
4.3 Global Human Hepatitis B Immunoglobulin (IM) Price Market Share by Type (2015-2020)
4.4 Global Human Hepatitis B Immunoglobulin (IM) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Human Hepatitis B Immunoglobulin (IM) Historic Market Analysis by Application
5.1 Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
5.2 Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Application (2015-2020)
5.3 Global Human Hepatitis B Immunoglobulin (IM) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Human Hepatitis B Immunoglobulin (IM) Business
6.1 Baxter
6.1.1 Corporation Information
6.1.2 Baxter Description, Business Overview and Total Revenue
6.1.3 Baxter Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Baxter Products Offered
6.1.5 Baxter Recent Development
6.2 CSL
6.2.1 CSL Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.2.2 CSL Description, Business Overview and Total Revenue
6.2.3 CSL Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CSL Products Offered
6.2.5 CSL Recent Development
6.3 Bayer
6.3.1 Bayer Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.3.2 Bayer Description, Business Overview and Total Revenue
6.3.3 Bayer Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Bayer Products Offered
6.3.5 Bayer Recent Development
6.4 Grifols
6.4.1 Grifols Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.4.2 Grifols Description, Business Overview and Total Revenue
6.4.3 Grifols Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Grifols Products Offered
6.4.5 Grifols Recent Development
6.5 Octapharma
6.5.1 Octapharma Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.5.2 Octapharma Description, Business Overview and Total Revenue
6.5.3 Octapharma Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Octapharma Products Offered
6.5.5 Octapharma Recent Development
6.6 Shanghai RAAS
6.6.1 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.6.2 Shanghai RAAS Description, Business Overview and Total Revenue
6.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Shanghai RAAS Products Offered
6.6.5 Shanghai RAAS Recent Development
6.7 Hualan Biological
6.6.1 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.6.2 Hualan Biological Description, Business Overview and Total Revenue
6.6.3 Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hualan Biological Products Offered
6.7.5 Hualan Biological Recent Development
6.8 China Biologic
6.8.1 China Biologic Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.8.2 China Biologic Description, Business Overview and Total Revenue
6.8.3 China Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 China Biologic Products Offered
6.8.5 China Biologic Recent Development
6.9 Tiantan Biologic
6.9.1 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.9.2 Tiantan Biologic Description, Business Overview and Total Revenue
6.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Tiantan Biologic Products Offered
6.9.5 Tiantan Biologic Recent Development
6.10 Shuanglin Bio-pharmacy
6.10.1 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.10.2 Shuanglin Bio-pharmacy Description, Business Overview and Total Revenue
6.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Shuanglin Bio-pharmacy Products Offered
6.10.5 Shuanglin Bio-pharmacy Recent Development
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.11.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Description, Business Overview and Total Revenue
6.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Sichuan Yuanda Shuyang Products Offered
6.11.5 Sichuan Yuanda Shuyang Recent Development
6.12 Boya Bio-pharmaceutical
6.12.1 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.12.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Description, Business Overview and Total Revenue
6.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Boya Bio-pharmaceutical Products Offered
6.12.5 Boya Bio-pharmaceutical Recent Development
6.13 Shanghai Institute of Biological
6.13.1 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Production Sites and Area Served
6.13.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Description, Business Overview and Total Revenue
6.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Shanghai Institute of Biological Products Offered
6.13.5 Shanghai Institute of Biological Recent Development
7 Human Hepatitis B Immunoglobulin (IM) Manufacturing Cost Analysis
7.1 Human Hepatitis B Immunoglobulin (IM) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (IM)
7.4 Human Hepatitis B Immunoglobulin (IM) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Hepatitis B Immunoglobulin (IM) Distributors List
8.3 Human Hepatitis B Immunoglobulin (IM) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Human Hepatitis B Immunoglobulin (IM) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Hepatitis B Immunoglobulin (IM) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Human Hepatitis B Immunoglobulin (IM) by Type (2021-2026)
10.2 Human Hepatitis B Immunoglobulin (IM) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Hepatitis B Immunoglobulin (IM) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Human Hepatitis B Immunoglobulin (IM) by Application (2021-2026)
10.3 Human Hepatitis B Immunoglobulin (IM) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Hepatitis B Immunoglobulin (IM) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Human Hepatitis B Immunoglobulin (IM) by Region (2021-2026)
10.4 North America Human Hepatitis B Immunoglobulin (IM) Estimates and Projections (2021-2026)
10.5 Europe Human Hepatitis B Immunoglobulin (IM) Estimates and Projections (2021-2026)
10.6 Asia Pacific Human Hepatitis B Immunoglobulin (IM) Estimates and Projections (2021-2026)
10.7 Latin America Human Hepatitis B Immunoglobulin (IM) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Human Hepatitis B Immunoglobulin (IM) Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Human Hepatitis B Immunoglobulin (IM) Manufacturers Covered in This Study
Table 5. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturers (2015-2020)
Table 7. Global Human Hepatitis B Immunoglobulin (IM) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Human Hepatitis B Immunoglobulin (IM) Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Human Hepatitis B Immunoglobulin (IM) Sales Sites and Area Served
Table 11. Manufacturers Human Hepatitis B Immunoglobulin (IM) Product Types
Table 12. Global Human Hepatitis B Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Hepatitis B Immunoglobulin (IM) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin (IM) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Human Hepatitis B Immunoglobulin (IM) Players
Table 16. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) by Region (2015-2020)
Table 17. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
Table 18. Global Human Hepatitis B Immunoglobulin (IM) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region (2015-2020)
Table 20. North America Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 21. North America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 22. North America Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 24. Europe Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 25. Europe Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 26. Europe Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 33. Latin America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 34. Latin America Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country (2015-2020)
Table 40. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) by Type (2015-2020)
Table 41. Global Human Hepatitis B Immunoglobulin (IM) Sales Share by Type (2015-2020)
Table 42. Global Human Hepatitis B Immunoglobulin (IM) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Human Hepatitis B Immunoglobulin (IM) Revenue Share by Type (2015-2020)
Table 44. Global Human Hepatitis B Immunoglobulin (IM) Price (USD/MT) by Type (2015-2020)
Table 45. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) by Application (2015-2020)
Table 46. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Table 47. Global Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate by Application (2015-2020)
Table 48. Baxter Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Baxter Main Product
Table 52. Baxter Recent Development
Table 53. CSL Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 54. CSL Corporation Information
Table 55. CSL Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. CSL Main Product
Table 57. CSL Recent Development
Table 58. Bayer Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 59. Bayer Corporation Information
Table 60. Bayer Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Bayer Main Product
Table 62. Bayer Recent Development
Table 63. Grifols Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 64. Grifols Corporation Information
Table 65. Grifols Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Grifols Main Product
Table 67. Grifols Recent Development
Table 68. Octapharma Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 69. Octapharma Corporation Information
Table 70. Octapharma Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Octapharma Main Product
Table 72. Octapharma Recent Development
Table 73. Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 74. Shanghai RAAS Corporation Information
Table 75. Shanghai RAAS Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Shanghai RAAS Main Product
Table 77. Shanghai RAAS Recent Development
Table 78. Hualan Biological Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 79. Hualan Biological Corporation Information
Table 80. Hualan Biological Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Hualan Biological Main Product
Table 82. Hualan Biological Recent Development
Table 83. China Biologic Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 84. China Biologic Corporation Information
Table 85. China Biologic Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. China Biologic Main Product
Table 87. China Biologic Recent Development
Table 88. Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 89. Tiantan Biologic Corporation Information
Table 90. Tiantan Biologic Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Tiantan Biologic Main Product
Table 92. Tiantan Biologic Recent Development
Table 93. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 94. Shuanglin Bio-pharmacy Corporation Information
Table 95. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Shuanglin Bio-pharmacy Main Product
Table 97. Shuanglin Bio-pharmacy Recent Development
Table 98. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 99. Sichuan Yuanda Shuyang Corporation Information
Table 100. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Sichuan Yuanda Shuyang Main Product
Table 102. Sichuan Yuanda Shuyang Recent Development
Table 103. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 104. Boya Bio-pharmaceutical Corporation Information
Table 105. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Boya Bio-pharmaceutical Main Product
Table 107. Boya Bio-pharmaceutical Recent Development
Table 108. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Corporation Information
Table 109. Shanghai Institute of Biological Corporation Information
Table 110. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (IM) Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Shanghai Institute of Biological Main Product
Table 112. Shanghai Institute of Biological Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Human Hepatitis B Immunoglobulin (IM) Distributors List
Table 116. Human Hepatitis B Immunoglobulin (IM) Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) Forecast by Type (2021-2026)
Table 121. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Human Hepatitis B Immunoglobulin (IM) Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Human Hepatitis B Immunoglobulin (IM) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) Forecast by Application (2021-2026)
Table 125. Global Human Hepatitis B Immunoglobulin (IM) Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Human Hepatitis B Immunoglobulin (IM) Sales (MT) Forecast by Region (2021-2026)
Table 127. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Human Hepatitis B Immunoglobulin (IM) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Human Hepatitis B Immunoglobulin (IM)
Figure 2. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Type: 2020 VS 2026
Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin (IM) Product Picture
Figure 6. Global Human Hepatitis B Immunoglobulin (IM) Consumption Market Share by Application: 2020 VS 2026
Figure 7. Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
Figure 8. Unexpected Crowd of Hepatitis B Infection
Figure 9. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 10. Global Human Hepatitis B Immunoglobulin (IM) Market Size 2015-2026 (US$ Million)
Figure 11. Global Human Hepatitis B Immunoglobulin (IM) Sales Capacity (MT) (2015-2026)
Figure 12. Global Human Hepatitis B Immunoglobulin (IM) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Human Hepatitis B Immunoglobulin (IM) Sales Share by Manufacturers in 2020
Figure 14. Global Human Hepatitis B Immunoglobulin (IM) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Hepatitis B Immunoglobulin (IM) Revenue in 2019
Figure 16. Human Hepatitis B Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region (2015-2020)
Figure 18. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region in 2019
Figure 19. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region (2015-2020)
Figure 20. Global Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region in 2019
Figure 21. North America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country in 2019
Figure 22. North America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country in 2019
Figure 23. U.S. Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 24. U.S. Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 26. Canada Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country in 2019
Figure 28. Europe Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country in 2019
Figure 29. Germany Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 30. Germany Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 32. France Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 34. U.K. Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 36. Italy Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 38. Russia Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Region in 2019
Figure 41. China Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 42. China Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 44. Japan Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 46. South Korea Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 48. India Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 50. Australia Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 52. Taiwan Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 54. Indonesia Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 56. Thailand Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 58. Malaysia Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 60. Philippines Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 62. Vietnam Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country in 2019
Figure 64. Latin America Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country in 2019
Figure 65. Mexico Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 66. Mexico Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 68. Brazil Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 70. Argentina Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Human Hepatitis B Immunoglobulin (IM) Revenue Market Share by Country in 2019
Figure 73. Turkey Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 74. Turkey Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 76. Saudi Arabia Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Human Hepatitis B Immunoglobulin (IM) Sales Growth Rate (2015-2020) (MT)
Figure 78. U.A.E Human Hepatitis B Immunoglobulin (IM) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Human Hepatitis B Immunoglobulin (IM) by Type (2015-2020)
Figure 80. Sales Market Share of Human Hepatitis B Immunoglobulin (IM) by Type in 2019
Figure 81. Revenue Share of Human Hepatitis B Immunoglobulin (IM) by Type (2015-2020)
Figure 82. Revenue Market Share of Human Hepatitis B Immunoglobulin (IM) by Type in 2019
Figure 83. Global Human Hepatitis B Immunoglobulin (IM) Sales Growth by Type (2015-2020) (MT)
Figure 84. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application (2015-2020)
Figure 85. Global Human Hepatitis B Immunoglobulin (IM) Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Human Hepatitis B Immunoglobulin (IM) by Application (2015-2020)
Figure 87. Global Revenue Share of Human Hepatitis B Immunoglobulin (IM) by Application in 2020
Figure 88. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Hualan Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. China Biologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Tiantan Biologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Shuanglin Bio-pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Boya Bio-pharmaceu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs